By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

A significant issue is under enrollment of women in randomized trials, meaning the percentage of women enrolled isn’t in line ...

A newly uncovered U.S. military report reveals that over 400 Japanese were mobilized to run the Class-B and C Yokohama war ...

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

"The Belt Collector" Mercedes Mone describes what it's like to carry all her groundbreaking titles around on a daily basis.

As part of the treatment trial, Jay does chemotherapy every other week for six months. Access to clinical trials is offered ...

A BRAIN implant has shown it can turn a person’s inner thoughts into words — but only if the user first thinks of a secret ...

The vaccine would train the immune system to fight cancer-causing mutations, according to new research from UCLA Health.

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight ...

The Russian nuclear-powered Kirov class cruiser RFS Admiral Nakhimov was observed on August 18th departing the Sevmash ...